{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:19:03Z","timestamp":1793683143411,"version":"4.5.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-025-01251-5","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T14:55:53Z","timestamp":1755183353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A self-amplifying mRNA vaccine expressing PRV gD induces robust immunity against virulent mutants"],"prefix":"10.1038","volume":"10","author":[{"given":"Tong","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huan-huan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Ya-ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Ya-mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Rong-li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando Mario","family":"Damiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Sai-sai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Chuan-jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duan","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Shu-yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jia-li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Qian-qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ruo-nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Osterrieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Shu-hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Ji-chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"1251_CR1","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1128\/MMBR.69.3.462-500.2005","volume":"69","author":"LE Pomeranz","year":"2005","unstructured":"Pomeranz, L. E., Reynolds, A. E. & Hengartner, C. J. Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine. Microbiol. Mol. Biol. Rev. 69, 462\u2013500 (2005).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"1251_CR2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3389\/fmicb.2020.00323","volume":"11","author":"J Ren","year":"2020","unstructured":"Ren, J. et al. Glycoproteins C and D of PRV Strain HB1201 contribute individually to the escape from Bartha-K61 vaccine-induced immunity. Front Microbiol 11, 323 (2020).","journal-title":"Front Microbiol"},{"key":"1251_CR3","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.1016\/j.vaccine.2020.07.025","volume":"38","author":"T Zhang","year":"2020","unstructured":"Zhang, T. et al. A single dose glycoprotein D-based subunit vaccine against pseudorabies virus infection. Vaccine 38, 6153\u20136161 (2020).","journal-title":"Vaccine"},{"key":"1251_CR4","doi-asserted-by":"publisher","first-page":"108886","DOI":"10.1016\/j.vetmic.2020.108886","volume":"251","author":"Z Jiang","year":"2020","unstructured":"Jiang, Z. et al. Immunogenicity and protective efficacy induced by an mRNA vaccine encoding gD antigen against pseudorabies virus infection. Vet. Microbiol. 251, 108886 (2020).","journal-title":"Vet. Microbiol."},{"key":"1251_CR5","doi-asserted-by":"publisher","first-page":"965997","DOI":"10.3389\/fmicb.2022.965997","volume":"13","author":"Z Cao","year":"2022","unstructured":"Cao, Z. et al. Efficacy of a gB + gD-based subunit vaccine and the adjuvant granulocyte-macrophage colony stimulating factor for pseudorabies virus in rabbits. Front. Microbiol. 13, 965997 (2022).","journal-title":"Front. Microbiol."},{"key":"1251_CR6","doi-asserted-by":"publisher","unstructured":"Bo, Z. & Li, X. A review of pseudorabies virus variants: genomics, vaccination, transmission, and zoonotic potential. Viruses https:\/\/doi.org\/10.3390\/v14051003 (2022).","DOI":"10.3390\/v14051003"},{"key":"1251_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.4142\/jvs.2013.14.3.363","volume":"14","author":"R Wu","year":"2013","unstructured":"Wu, R., Bai, C., Sun, J., Chang, S. & Zhang, X. Emergence of virulent pseudorabies virus infection in northern China. J. Vet. Sci. 14, 363\u2013365 (2013).","journal-title":"J. Vet. Sci."},{"key":"1251_CR8","doi-asserted-by":"publisher","unstructured":"Liu, Q. et al. The epidemiology and variation in pseudorabies virus: a continuing challenge to pigs and humans. Viruses https:\/\/doi.org\/10.3390\/v14071463 (2022).","DOI":"10.3390\/v14071463"},{"key":"1251_CR9","doi-asserted-by":"publisher","first-page":"e0529722","DOI":"10.1128\/spectrum.05297-22","volume":"11","author":"P Zhao","year":"2023","unstructured":"Zhao, P. et al. Epidemiological investigation, risk factors, spatial-temporal cluster, and epidemic trend analysis of pseudorabies virus seroprevalence in China (2017 to 2021). Microbiol. Spectr. 11, e0529722 (2023).","journal-title":"Microbiol. Spectr."},{"key":"1251_CR10","doi-asserted-by":"publisher","first-page":"e3690","DOI":"10.1093\/cid\/ciaa987","volume":"73","author":"Q Liu","year":"2021","unstructured":"Liu, Q. et al. A novel human acute encephalitis caused by pseudorabies virus variant strain. Clin. Infect. Dis. 73, e3690\u2013e3700 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"1251_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41392-023-01579-1","volume":"8","author":"G Zhang","year":"2023","unstructured":"Zhang, G., Tang, T., Chen, Y., Huang, X. & Liang, T. mRNA vaccines in disease prevention and treatment. Signal Transduct. Target Ther. 8, 365 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"1251_CR12","doi-asserted-by":"publisher","unstructured":"Gote, V. et al. A comprehensive review of mRNA vaccines. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms24032700 (2023).","DOI":"10.3390\/ijms24032700"},{"key":"1251_CR13","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/j.ymthe.2022.02.016","volume":"30","author":"GT Szab\u00f3","year":"2022","unstructured":"Szab\u00f3, G. T., Mahiny, A. J. & Vlatkovic, I. COVID-19 mRNA vaccines: platforms and current developments. Mol. Ther. 30, 1850\u20131868 (2022).","journal-title":"Mol. Ther."},{"key":"1251_CR14","first-page":"601","volume":"114","author":"HN Haq","year":"2022","unstructured":"Haq, H. N. et al. Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273) COVID-19 mRNA vaccines and hypersensitivity reactions. J. Natl Med. Assoc. 114, 601\u2013612 (2022).","journal-title":"J. Natl Med. Assoc."},{"key":"1251_CR15","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.antiviral.2009.12.005","volume":"85","author":"MR Pulido","year":"2010","unstructured":"Pulido, M. R., Sobrino, F., Borrego, B. & S\u00e1iz, M. RNA immunization can protect mice against foot-and-mouth disease virus. Antivir. Res. 85, 556\u2013558 (2010).","journal-title":"Antivir. Res."},{"key":"1251_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2389115","volume":"13","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice. Emerg. Microbes Infect. 13, 2389115 (2024).","journal-title":"Emerg. Microbes Infect."},{"key":"1251_CR17","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ymthe.2017.11.017","volume":"26","author":"AB Vogel","year":"2018","unstructured":"Vogel, A. B. et al. Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses. Mol. Ther. 26, 446\u2013455 (2018).","journal-title":"Mol. Ther."},{"key":"1251_CR18","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1073\/pnas.0307145101","volume":"101","author":"RM Kofler","year":"2004","unstructured":"Kofler, R. M. et al. Mimicking live flavivirus immunization with a noninfectious RNA vaccine. Proc. Natl Acad. Sci. USA 101, 1951\u20131956 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1251_CR19","doi-asserted-by":"publisher","first-page":"e0295823","DOI":"10.1128\/mbio.02958-23","volume":"15","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. PEDV-spike-protein-expressing mRNA vaccine protects piglets against PEDV challenge. mBio 15, e0295823 (2024).","journal-title":"mBio"},{"key":"1251_CR20","doi-asserted-by":"publisher","first-page":"e0053524","DOI":"10.1128\/jvi.00535-24","volume":"98","author":"J Li","year":"2024","unstructured":"Li, J. et al. A spike-based mRNA vaccine that induces durable and broad protection against porcine deltacoronavirus in piglets. J. Virol. 98, e0053524 (2024).","journal-title":"J. Virol."},{"key":"1251_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2204151","volume":"12","author":"J Zeng","year":"2023","unstructured":"Zeng, J. et al. Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge. Emerg. Microbes Infect. 12, 2204151 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"1251_CR22","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.cell.2024.01.017","volume":"187","author":"A Zuiani","year":"2024","unstructured":"Zuiani, A. et al. A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease. Cell 187, 1363\u20131373.e1312 (2024).","journal-title":"Cell"},{"key":"1251_CR23","doi-asserted-by":"publisher","unstructured":"Silva-Pilipich, N., Beloki, U., Salaberry, L. & Smerdou, C. Self-amplifying RNA: a second revolution of mRNA vaccines against COVID-19. Vaccines https:\/\/doi.org\/10.3390\/vaccines12030318 (2024).","DOI":"10.3390\/vaccines12030318"},{"key":"1251_CR24","doi-asserted-by":"publisher","first-page":"103341","DOI":"10.1016\/j.drudis.2022.103341","volume":"27","author":"MM Pourseif","year":"2022","unstructured":"Pourseif, M. M. et al. Self-amplifying mRNA vaccines: Mode of action, design, development and optimization. Drug Discov. Today 27, 103341 (2022).","journal-title":"Drug Discov. Today"},{"key":"1251_CR25","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.vaccine.2017.01.003","volume":"35","author":"J Zhou","year":"2017","unstructured":"Zhou, J., Li, S., Wang, X., Zou, M. & Gao, S. Bartha-k61 vaccine protects growing pigs against challenge with an emerging variant pseudorabies virus. Vaccine 35, 1161\u20131166 (2017).","journal-title":"Vaccine"},{"key":"1251_CR26","doi-asserted-by":"publisher","first-page":"976220","DOI":"10.3389\/fmicb.2022.976220","volume":"13","author":"T Hua","year":"2022","unstructured":"Hua, T. et al. Protective efficacy of intranasal inactivated pseudorabies vaccine is improved by combination adjuvant in mice. Front. Microbiol. 13, 976220 (2022).","journal-title":"Front. Microbiol."},{"key":"1251_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.virusres.2014.09.003","volume":"195","author":"Z Gu","year":"2015","unstructured":"Gu, Z. et al. A novel inactivated gE\/gI deleted pseudorabies virus (PRV) vaccine completely protects pigs from an emerged variant PRV challenge. Virus Res. 195, 57\u201363 (2015).","journal-title":"Virus Res."},{"key":"1251_CR28","doi-asserted-by":"publisher","first-page":"109799","DOI":"10.1016\/j.vetmic.2023.109799","volume":"284","author":"X Ren","year":"2023","unstructured":"Ren, X. et al. A self-assembled nanoparticle vaccine based on pseudorabies virus glycoprotein D induces potent protective immunity against pseudorabies virus infection. Vet. Microbiol. 284, 109799 (2023).","journal-title":"Vet. Microbiol."},{"key":"1251_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12985-022-01748-8","volume":"19","author":"L Sun","year":"2022","unstructured":"Sun, L., Tang, Y., Yan, K. & Zhang, H. Construction of a quadruple gene-deleted vaccine confers complete protective immunity against emerging PRV variant challenge in piglets. Virol. J. 19, 19 (2022).","journal-title":"Virol. J."},{"key":"1251_CR30","doi-asserted-by":"publisher","first-page":"109931","DOI":"10.1016\/j.vetmic.2023.109931","volume":"288","author":"Z Ma","year":"2024","unstructured":"Ma, Z. et al. Pathogenicity and immunogenicity of a quadruple gene-deleted pseudorabies virus variant as a vaccine candidate. Vet. Microbiol. 288, 109931 (2024).","journal-title":"Vet. Microbiol."},{"key":"1251_CR31","doi-asserted-by":"publisher","first-page":"1248573","DOI":"10.3389\/fmicb.2023.1248573","volume":"14","author":"M Xu","year":"2023","unstructured":"Xu, M. et al. Construction of pseudorabies virus variant attenuated vaccine: codon deoptimization of US3 and UL56 genes based on PRV gE\/TK deletion strain. Front. Microbiol. 14, 1248573 (2023).","journal-title":"Front. Microbiol."},{"key":"1251_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-022-00950-y","volume":"7","author":"E Fang","year":"2022","unstructured":"Fang, E. et al. Advances in COVID-19 mRNA vaccine development. Signal Transduct. Target Ther. 7, 94 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"1251_CR33","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1177\/08971900211009650","volume":"35","author":"SP Teo","year":"2022","unstructured":"Teo, S. P. Review of COVID-19 mRNA vaccines: BNT162b2 and mRNA-1273. J. Pharm. Pract. 35, 947\u2013951 (2022).","journal-title":"J. Pharm. Pract."},{"key":"1251_CR34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.cmi.2021.10.005","volume":"28","author":"T Fiolet","year":"2022","unstructured":"Fiolet, T., Kherabi, Y., MacDonald, C. J., Ghosn, J. & Peiffer-Smadja, N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin. Microbiol. Infect. 28, 202\u2013221 (2022).","journal-title":"Clin. Microbiol. Infect."},{"key":"1251_CR35","doi-asserted-by":"publisher","unstructured":"Xu, S., Yang, K., Li, R. & Zhang, L. mRNA vaccine era-mechanisms, drug platform and clinical prospection. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21186582 (2020).","DOI":"10.3390\/ijms21186582"},{"key":"1251_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.molmed.2019.10.002","volume":"26","author":"S Linares-Fern\u00e1ndez","year":"2020","unstructured":"Linares-Fern\u00e1ndez, S., Lacroix, C., Exposito, J. Y. & Verrier, B. Tailoring mRNA vaccine to balance innate\/adaptive immune response. Trends Mol. Med. 26, 311\u2013323 (2020).","journal-title":"Trends Mol. Med."},{"key":"1251_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-024-02174-7","author":"H Chen","year":"2024","unstructured":"Chen, H. et al. Branched chemically modified poly(A) tails enhance the translation capacity of mRNA. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-024-02174-7 (2024).","journal-title":"Nat. Biotechnol."},{"key":"1251_CR38","doi-asserted-by":"publisher","first-page":"e0024422","DOI":"10.1128\/mcb.00244-22","volume":"42","author":"KH Lui","year":"2022","unstructured":"Lui, K. H., Geisberg, J. V., Moqtaderi, Z. & Struhl, K. 3\u2019 Untranslated regions are modular entities that determine polyadenylation profiles. Mol. Cell Biol. 42, e0024422 (2022).","journal-title":"Mol. Cell Biol."},{"key":"1251_CR39","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1016\/j.ymthe.2022.04.014","volume":"30","author":"S McCafferty","year":"2022","unstructured":"McCafferty, S. et al. A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity. Mol. Ther. 30, 2968\u20132983 (2022).","journal-title":"Mol. Ther."},{"key":"1251_CR40","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/j.cell.2024.03.018","volume":"187","author":"CJ Wayne","year":"2024","unstructured":"Wayne, C. J. & Blakney, A. K. Self-amplifying RNA COVID-19 vaccine. Cell 187, 1822\u20131822.e1821 (2024).","journal-title":"Cell"},{"key":"1251_CR41","doi-asserted-by":"publisher","first-page":"1288458","DOI":"10.3389\/fmicb.2023.1288458","volume":"14","author":"M Zhao","year":"2023","unstructured":"Zhao, M. et al. Pseudorabies gD protein protects mice and piglets against lethal doses of pseudorabies virus. Front. Microbiol. 14, 1288458 (2023).","journal-title":"Front. Microbiol."},{"key":"1251_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41628-5","volume":"14","author":"F Hou","year":"2023","unstructured":"Hou, F. et al. mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge. Nat. Commun. 14, 5925 (2023).","journal-title":"Nat. Commun."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01251-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01251-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01251-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:54:58Z","timestamp":1757458498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01251-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1251"],"URL":"https:\/\/doi.org\/10.1038\/s41541-025-01251-5","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"193"}}